UniQure stock dropped after the FDA sent feedback on the company's pending treatment for Huntington's disease. Read more on ...
Failure by municipal and national governments in any given country to provide adequately for the needs of both small, medium and large business enterprises can significantly reduce the potential of ...
Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback